HealthPlix Technologies raises around Rs 181 crore in Series C funding

Published On 2023-03-16 09:45 GMT   |   Update On 2023-03-16 09:45 GMT
Advertisement

New Delhi: Health tech startup HealthPlix Technologies on Wednesday said it has raised $22 million (around Rs 181 crore) in Series C funding led by Avataar Venture Partners, SIG Venture Capital and existing investors.

The fresh capital will be used to ramp up product innovation, enhance the technology stack and scale user acquisition efforts.
"At HealthPlix, our vision is to drive better health outcomes at population level. Today, we serve 2.5 percent of the entire Indian population. With these new funds, we aim to cater to 200-250 million more patient lives in an 18-month time frame," HealthPlix Technologies co-founder & CEO Sandeep Gudibanda said in a statement.
Advertisement
Last year, the Bengaluru-based firm had secured $2 million in debt funding from Blacksoil Ventures.

Read also: HealthPlix raises over Rs 99 crore in Series B funding led by Lightspeed





Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News